A bit off-topic here (this is a health-related study), but here’s an illustration of the benefits of IRB shopping.
[Cordner, Alissa, and Phil Brown. “Moments of Uncertainty: Ethical Considerations and Emerging Contaminants.” Sociological Forum 28, no. 3 (September 2013): 469–94. doi:10.1111/socf.12034.]
Breast milk biomonitoring can be controversial because of concerns that the reporting-back of individual contamination levels may discourage breastfeeding (Morello-Frosch et al. 2009), thus potentially balancing identifiable benefits to science with uncertain benefits and harms to participants. Breastfeeding provides important health benefits compared to formula feeding, even when the milk contains chemicals (Hooper and She 2003; Jorissen 2007), but some academics and IRBs worry that a woman’s knowledge of her body burden could impact her decision to breastfeed. Yet evidence supporting these fears is based on hypothetical situations described in survey research (Geraghty et al. 2008) or is anecdotal (Gross-Loh 2004). A recent study of women who shared their breast milk for a biomonitoring project found that while some women in this study stated they became more aware of chemical exposure and some made lifestyle changes, none of them chose to stop breastfeeding or to breastfeed for a shorter period of time because of their study results (Wu et al. 2009).
As an example of this ethical concern around breast milk biomonitoring research, one scientist’s IRB initially denied a research protocol that would have tested for chemicals in breast milk on the grounds that the scientific benefits of learning about breast milk contamination did not outweigh the potential risks to women learning about personal contamination.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.